Lupus Nephritis Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: L1C282C34308EN
Market Monitor Global

Abstracts

Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men.

This report contains market size and forecasts of Lupus Nephritis in Global, including the following market information:

Global Lupus Nephritis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lupus Nephritis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnose Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lupus Nephritis include Roche, Merck, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline and myVMC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lupus Nephritis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lupus Nephritis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lupus Nephritis Market Segment Percentages, by Type, 2021 (%)

• Diagnose
• Medications

Global Lupus Nephritis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lupus Nephritis Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmaceutical Companies

Global Lupus Nephritis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lupus Nephritis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lupus Nephritis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lupus Nephritis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Merck
• Bristol-Myers Squibb
• Eli Lilly
• GlaxoSmithKline
• myVMC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lupus Nephritis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lupus Nephritis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LUPUS NEPHRITIS OVERALL MARKET SIZE

2.1 Global Lupus Nephritis Market Size: 2021 VS 2028
2.2 Global Lupus Nephritis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lupus Nephritis Players in Global Market
3.2 Top Global Lupus Nephritis Companies Ranked by Revenue
3.3 Global Lupus Nephritis Revenue by Companies
3.4 Top 3 and Top 5 Lupus Nephritis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lupus Nephritis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lupus Nephritis Players in Global Market
  3.6.1 List of Global Tier 1 Lupus Nephritis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lupus Nephritis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lupus Nephritis Market Size Markets, 2021 & 2028
  4.1.2 Diagnose
  4.1.3 Medications
4.2 By Type - Global Lupus Nephritis Revenue & Forecasts
  4.2.1 By Type - Global Lupus Nephritis Revenue, 2017-2022
  4.2.2 By Type - Global Lupus Nephritis Revenue, 2023-2028
  4.2.3 By Type - Global Lupus Nephritis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lupus Nephritis Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Pharmaceutical Companies
5.2 By Application - Global Lupus Nephritis Revenue & Forecasts
  5.2.1 By Application - Global Lupus Nephritis Revenue, 2017-2022
  5.2.2 By Application - Global Lupus Nephritis Revenue, 2023-2028
  5.2.3 By Application - Global Lupus Nephritis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lupus Nephritis Market Size, 2021 & 2028
6.2 By Region - Global Lupus Nephritis Revenue & Forecasts
  6.2.1 By Region - Global Lupus Nephritis Revenue, 2017-2022
  6.2.2 By Region - Global Lupus Nephritis Revenue, 2023-2028
  6.2.3 By Region - Global Lupus Nephritis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lupus Nephritis Revenue, 2017-2028
  6.3.2 US Lupus Nephritis Market Size, 2017-2028
  6.3.3 Canada Lupus Nephritis Market Size, 2017-2028
  6.3.4 Mexico Lupus Nephritis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lupus Nephritis Revenue, 2017-2028
  6.4.2 Germany Lupus Nephritis Market Size, 2017-2028
  6.4.3 France Lupus Nephritis Market Size, 2017-2028
  6.4.4 U.K. Lupus Nephritis Market Size, 2017-2028
  6.4.5 Italy Lupus Nephritis Market Size, 2017-2028
  6.4.6 Russia Lupus Nephritis Market Size, 2017-2028
  6.4.7 Nordic Countries Lupus Nephritis Market Size, 2017-2028
  6.4.8 Benelux Lupus Nephritis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lupus Nephritis Revenue, 2017-2028
  6.5.2 China Lupus Nephritis Market Size, 2017-2028
  6.5.3 Japan Lupus Nephritis Market Size, 2017-2028
  6.5.4 South Korea Lupus Nephritis Market Size, 2017-2028
  6.5.5 Southeast Asia Lupus Nephritis Market Size, 2017-2028
  6.5.6 India Lupus Nephritis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lupus Nephritis Revenue, 2017-2028
  6.6.2 Brazil Lupus Nephritis Market Size, 2017-2028
  6.6.3 Argentina Lupus Nephritis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lupus Nephritis Revenue, 2017-2028
  6.7.2 Turkey Lupus Nephritis Market Size, 2017-2028
  6.7.3 Israel Lupus Nephritis Market Size, 2017-2028
  6.7.4 Saudi Arabia Lupus Nephritis Market Size, 2017-2028
  6.7.5 UAE Lupus Nephritis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Lupus Nephritis Major Product Offerings
  7.1.4 Roche Lupus Nephritis Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Lupus Nephritis Major Product Offerings
  7.2.4 Merck Lupus Nephritis Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Lupus Nephritis Major Product Offerings
  7.3.4 Bristol-Myers Squibb Lupus Nephritis Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Lupus Nephritis Major Product Offerings
  7.4.4 Eli Lilly Lupus Nephritis Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Lupus Nephritis Major Product Offerings
  7.5.4 GlaxoSmithKline Lupus Nephritis Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 myVMC
  7.6.1 myVMC Corporate Summary
  7.6.2 myVMC Business Overview
  7.6.3 myVMC Lupus Nephritis Major Product Offerings
  7.6.4 myVMC Lupus Nephritis Revenue in Global Market (2017-2022)
  7.6.5 myVMC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lupus Nephritis Market Opportunities & Trends in Global Market
Table 2. Lupus Nephritis Market Drivers in Global Market
Table 3. Lupus Nephritis Market Restraints in Global Market
Table 4. Key Players of Lupus Nephritis in Global Market
Table 5. Top Lupus Nephritis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lupus Nephritis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lupus Nephritis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lupus Nephritis Product Type
Table 9. List of Global Tier 1 Lupus Nephritis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lupus Nephritis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lupus Nephritis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lupus Nephritis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lupus Nephritis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lupus Nephritis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lupus Nephritis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lupus Nephritis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lupus Nephritis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lupus Nephritis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lupus Nephritis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lupus Nephritis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lupus Nephritis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lupus Nephritis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lupus Nephritis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lupus Nephritis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lupus Nephritis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lupus Nephritis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lupus Nephritis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lupus Nephritis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lupus Nephritis Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Lupus Nephritis Product Offerings
Table 32. Roche Lupus Nephritis Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Lupus Nephritis Product Offerings
Table 35. Merck Lupus Nephritis Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Lupus Nephritis Product Offerings
Table 38. Bristol-Myers Squibb Lupus Nephritis Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Lupus Nephritis Product Offerings
Table 41. Eli Lilly Lupus Nephritis Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Lupus Nephritis Product Offerings
Table 44. GlaxoSmithKline Lupus Nephritis Revenue (US$, Mn), (2017-2022)
Table 45. myVMC Corporate Summary
Table 46. myVMC Lupus Nephritis Product Offerings
Table 47. myVMC Lupus Nephritis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lupus Nephritis Segment by Type in 2021
Figure 2. Lupus Nephritis Segment by Application in 2021
Figure 3. Global Lupus Nephritis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lupus Nephritis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lupus Nephritis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lupus Nephritis Revenue in 2021
Figure 8. By Type - Global Lupus Nephritis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lupus Nephritis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lupus Nephritis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lupus Nephritis Revenue Market Share, 2017-2028
Figure 12. US Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lupus Nephritis Revenue Market Share, 2017-2028
Figure 16. Germany Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 17. France Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lupus Nephritis Revenue Market Share, 2017-2028
Figure 24. China Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 28. India Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lupus Nephritis Revenue Market Share, 2017-2028
Figure 30. Brazil Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lupus Nephritis Revenue Market Share, 2017-2028
Figure 33. Turkey Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lupus Nephritis Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. myVMC Lupus Nephritis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)